4
Changes in Ownership
MBX Biosciences, Inc. Filed Acc 0000950170-24-107489
10% owner acquired 1,790,122 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner | 2024-09-16 | Conversion | +1,386,335 | 1,386,335 | D: show line 1 in the form | ||
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner | 2024-09-16 | Conversion | +403,787 | 1,790,122 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner | 2024-09-16 | Conversion · Series B Preferred Stock | −16,666,666 | 0 | D: show line 3 in the form | ||
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner | 2024-09-16 | Conversion · Series C Preferred Stock | −4,854,368 | 0 | D: show line 4 in the form |
Loading xslF345X05/ownership.xml…